Strong Tower Advisory Services Has $6.79 Million Position in UnitedHealth Group Incorporated $UNH

Strong Tower Advisory Services grew its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 2.8% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 21,778 shares of the healthcare conglomerate’s stock after purchasing an additional 592 shares during the quarter. UnitedHealth Group comprises 1.3% of Strong Tower Advisory Services’ portfolio, making the stock its 25th biggest holding. Strong Tower Advisory Services’ holdings in UnitedHealth Group were worth $6,794,000 at the end of the most recent quarter.

Several other hedge funds have also made changes to their positions in the stock. Bensler LLC lifted its stake in shares of UnitedHealth Group by 0.3% in the first quarter. Bensler LLC now owns 6,945 shares of the healthcare conglomerate’s stock valued at $3,637,000 after buying an additional 22 shares during the period. Lakeridge Wealth Management LLC lifted its stake in shares of UnitedHealth Group by 5.8% in the first quarter. Lakeridge Wealth Management LLC now owns 420 shares of the healthcare conglomerate’s stock valued at $220,000 after buying an additional 23 shares during the period. Nabity Jensen Investment Management Inc lifted its stake in shares of UnitedHealth Group by 0.9% in the first quarter. Nabity Jensen Investment Management Inc now owns 2,760 shares of the healthcare conglomerate’s stock valued at $1,446,000 after buying an additional 24 shares during the period. BigSur Wealth Management LLC lifted its stake in shares of UnitedHealth Group by 0.5% in the first quarter. BigSur Wealth Management LLC now owns 4,743 shares of the healthcare conglomerate’s stock valued at $2,484,000 after buying an additional 25 shares during the period. Finally, Atlantic Edge Private Wealth Management LLC lifted its stake in UnitedHealth Group by 8.9% during the first quarter. Atlantic Edge Private Wealth Management LLC now owns 305 shares of the healthcare conglomerate’s stock worth $160,000 after purchasing an additional 25 shares during the period. Institutional investors own 87.86% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts have commented on the stock. Zacks Research upgraded shares of UnitedHealth Group from a “strong sell” rating to a “hold” rating in a research note on Monday, October 6th. Robert W. Baird restated an “underperform” rating and set a $198.00 price target (down previously from $312.00) on shares of UnitedHealth Group in a research note on Thursday, July 31st. Weiss Ratings restated a “sell (d+)” rating on shares of UnitedHealth Group in a research note on Wednesday. Barclays lifted their target price on shares of UnitedHealth Group from $352.00 to $386.00 and gave the company an “overweight” rating in a research note on Thursday. Finally, Baird R W cut shares of UnitedHealth Group from a “hold” rating to a “strong sell” rating in a research note on Thursday, July 31st. Sixteen research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and four have given a Sell rating to the company. Based on data from MarketBeat, UnitedHealth Group currently has an average rating of “Hold” and an average price target of $383.09.

UnitedHealth Group Stock Performance

UNH stock opened at $354.30 on Friday. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85. The company has a 50 day moving average price of $318.21 and a 200 day moving average price of $350.41. UnitedHealth Group Incorporated has a fifty-two week low of $234.60 and a fifty-two week high of $630.73. The stock has a market capitalization of $320.88 billion, a PE ratio of 15.35, a price-to-earnings-growth ratio of 2.38 and a beta of 0.47.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The company had revenue of $111.62 billion during the quarter, compared to the consensus estimate of $111.75 billion. During the same quarter last year, the firm earned $6.80 EPS. The business’s revenue for the quarter was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th were given a dividend of $2.21 per share. The ex-dividend date was Monday, September 15th. This represents a $8.84 annualized dividend and a dividend yield of 2.5%. UnitedHealth Group’s payout ratio is presently 38.30%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.